PMV Pharmaceuticals, Inc. (PMVP) › Capital ExpendituresPMV Pharmaceuticals, Inc. (PMVP) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $452.0K2019: $109.0K2020: $148.0K2021: $1.35M2022: $7.98M2023: $962.0K2024: $655.0K2025: $29.0K$29.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$29.0K-95.6%2024$655.0K-31.9%2023$962.0K-88.0%2022$7.98M+491.8%2021$1.35M+811.5%2020$148.0K+35.8%2019$109.0K-75.9%2018$452.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share